Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in California.
Saved in:
| Title: | Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in California. |
|---|---|
| Authors: | Katrak SS; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.; Division of Infectious Diseases, School of Medicine, University of California, San Francisco, California, USA., Wang RC; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA., Keh CE; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.; Division of Infectious Diseases, School of Medicine, University of California, San Francisco, California, USA., Nabity SA; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Okada RC; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA., Raftery A; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA., Wendorf KA; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA., Agraz-Lara R; TB Prevention and Control Program, San Francisco Department of Public Health, San Francisco, California, USA., Chakrabarty M; Chest Clinic, Sacramento County Public Health, Sacramento, California, USA., Chevinsky JR; Riverside University Health System, Riverside County Department of Public Health, Riverside, California, USA., Chitnis AS; Tuberculosis Section, Division of Communicable Disease Control and Prevention, Alameda County Public Health Department, San Leandro, California, USA., Dasgupta-Tsinikas S; Tuberculosis Control Program, Los Angeles County Department of Public Health, Inglewood, California, USA., Goozé L; Tuberculosis Control Program, San Mateo County Public Health Department, San Mateo, California, USA., Kadakia A; Tuberculosis Prevention and Care Branch, Public Health Services, County of San Diego Health and Human Services Agency, San Diego, California, USA., Kaiser C; Solano County Department of Public Health, Fairfield, California, USA., Louie JK; TB Prevention and Control Program, San Francisco Department of Public Health, San Francisco, California, USA., Morgan J; Solano County Department of Public Health, Fairfield, California, USA., Nguyen TD; Tuberculosis Prevention and Care Branch, Public Health Services, County of San Diego Health and Human Services Agency, San Diego, California, USA., Percak J; Tuberculosis Prevention and Care Branch, Public Health Services, County of San Diego Health and Human Services Agency, San Diego, California, USA., Polesky AH; Tuberculosis Prevention and Care Branch, Public Health Services, County of San Diego Health and Human Services Agency, San Diego, California, USA., Radner A; Tuberculosis Control Unit, County of Monterey Health Department, Salinas, California, USA., Sahni H; Santa Clara Valley Healthcare, County of Santa Clara, San Jose, California, USA., Sreenivasan M; Contra Costa Department of Public Health, Concord, California, USA., Sherrick R; County of Santa Barbara Public Health, Communicable Disease Control and Prevention Division, Santa Maria, California, USA., Soukup JD; Tuberculosis Control Program, Los Angeles County Department of Public Health, Inglewood, California, USA., Waterman C; Tuberculosis Control Program, San Mateo County Public Health Department, San Mateo, California, USA., Yeturu P; Santa Clara Valley Healthcare, County of Santa Clara, San Jose, California, USA., Yu S; Tuberculosis Control Program, Los Angeles County Department of Public Health, Inglewood, California, USA., Barry PM; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.; Division of Infectious Diseases, School of Medicine, University of California, San Francisco, California, USA. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2026 May 07; Vol. 13 (5), pp. ofag220. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofag220 |
